欢迎访问ProbeChem中文网站，英文网站请访问www.probechem.com
    英文 |     中文

产品咨询: sales@probechem.com
订购: order@probechem.com

首页-小分子抑制剂&激动剂-Ras-Raf-MAPK-ERK Pathway-p38 MAPK-LY2228820 dimesylate
LY2228820 dimesylate

Chemical Structure : LY2228820 dimesylate

CAS No.: 862507-23-1

加入收藏

LY2228820 dimesylate (Ralimetinib dimesylate, LY-2228820)

货号: PC-43421Not For Human Use, Lab Use Only.

LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.

规格 价格 库存 数量
10 mg ￥980 In stock
50 mg ￥2180 In stock
100 mg ￥3580 In stock
250 mg Get quote
获取报价单
* 请选择数量再加入购物车
 or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.
LY2228820 dimesylate (Ralimetinib) potently and selectively inhibits phosphorylation of MK2 (Thr334) in anisomycin-stimulated HeLa cells and mouse RAW264.7 macrophages (IC50=35.3 nM), with no changes in phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc.
LY2228820 dimesylate (Ralimetinib) also reduces TNF-α secretion by LPS/IFN-γ–stimulated macrophages with IC50 of 6.3 nM.
LY2228820 dimesylate (Ralimetinib) produces significant tumor growth delay in multiple in vivo cancer models (melanoma, non-small cell lung cancer, ovarian, glioma, myeloma, breast).

物理化学性质&存储条件

分子量 612.737
分子式 C26H37FN6O6S2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

DMSO: < 7.8 mg/mL
Chemical Name/SMILES

3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-, methanesulfonate (1:2)

参考文献

1. Tate CM, et al. J Biol Chem. 2013 Mar 1;288(9):6743-53.

2. Campbell RM, et al. Mol Cancer Ther. 2014 Feb;13(2):364-74.

3. Ishitsuka K, et al. Br J Haematol. 2008 May;141(5):598-606.

4. Patnaik A, et al. Clin Cancer Res. 2016 Mar 1;22(5):1095-102.

备案号：沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: